title: Genetic Counseling for Patients Considering Screening and Diagnosis for Chromosomal Abnormalities.
abstract: With the introduction of cell-free DNA screening for fetal aneuploidy and chromosomal microarray for prenatal diagnostic testing, options for pregnant women have become increasingly complex. Discussions regarding options for prenatal testing for aneuploidy should occur prior to any testing and should include pertinent risks and benefits of each alternative test. There is no single screening or diagnostic test option that is the right choice for all patients; patient decisions should be based on each individual woman's values and preferences after a discussion of all options.
authors.affiliation: Division of Maternal-Fetal Medicine, Maine Medical Partners Women's Health, 887 Congress Street, Suite 200, Portland, ME 04102, USA.
authors.forename: Renée L
authors.initials: RL
authors.lastname: Chard
authors.affiliation: Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, 550 16th Street, 7th Floor, San Francisco, CA 94143, USA. Electronic address: mary.norton@ucsf.edu.
authors.forename: Mary E
authors.initials: ME
authors.lastname: Norton
mesh_terms: D003657:Decision Making; D005260:Female; D005817:Genetic Counseling; D006801:Humans; D011247:Pregnancy; D011296:Prenatal Diagnosis / Q000523:psychology*; D018570:Risk Assessment
keywords: Amniocentesis; Chorionic villi sampling; Chromosome abnormalities; Genetic counseling; Maternal serum multiple marker screening; Noninvasive prenatal screening; Prenatal care